EFTA-India Free Trade Agreement and Patents Rules Amendment: Compromising Public Accountability and Transparency in the Indian Patent System
SpicyIP
APRIL 7, 2024
She has been working on patent oppositions and was involved in patent challenges on key drugs including the Gleevec-Novartis case. provides for dismissing pre-grant oppositions by the controller if they consider it to have been filed on unfounded grounds. The implications of the amended Rules and TEPA are discussed later in the post.)
72 
Let's personalize your content